Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

16.57 -0.02 (-0.12%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
24 25 Next >
Volume Surges Spark Turnarounds for These 3 Stocks
There are countless historical chart examples of high volume moves that mark the beginning of sustained rallies or slumps. Let’s tune into a few examples. 
Via MarketBeat
Topics Lawsuit
Exposures Financial Legal
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate'
Following Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) opioid settlement, the Tel Aviv-Yafo, Israel-based company seems to be making “material progress” in clearing its litigation overhangs. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Upgrades 
Via Benzinga
Teva Pharmaceutical Soars On $75 Million Opioid Deal In West Virginia
Teva will also provide the state with free opioid overdose treatment for a decade. 
Via Investor's Business Daily
Synaptics To $205? Plus Stifel Cuts Twilio's PT From $200 To This Level
Stifel cut the price target for Twilio Inc. (NYSE: TWLO) from $200 to $90. Twilio shares fell 9.6% to $88.75 in pre-market trading. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
Analysts have provided the following ratings for Teva Pharmaceutical Indus (NYSE:TEVA) within the last quarter: 
Via Benzinga
Cramer Says This Stock Is Losing Money As 'Too Many Companies Doing The Same Thing'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Marqeta Inc (NASDAQ: MQ) adding that "too many companies doing the same thing as they are, and they’re losing money." 
Via Benzinga
Bausch Health (BHC) Stock Plunges 50% on Patent News
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled. 
Via InvestorPlace
Allergan To End Around 3,000 Opioid Lawsuits With Over $2B In Settlement: Report
Via Benzinga
PayPal, Alphabet And Some Other Big Stocks Recording Gains On Wednesday
U.S. stocks closed sharply higher on Wednesday, with the Dow Jones jumping more than 400 points. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Most Active Equity Options For Midday - Wednesday, July 27
Here are the most active equity options for midday. 
Via Talk Markets
Dow Rises 150 Points As Fed Boosts Rates By 0.75 Percentage Points
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. 
Via Benzinga
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
Nasdaq Jumps Over 300 Points; Boeing Posts Wider-Than-Expected Loss
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday. 
Via Benzinga
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits
Teva Pharmaceuticals (TEVA) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits. 
Via InvestorPlace
Why Teva Pharmaceutical Industries Stock Is Soaring
Teva Pharmaceutical Industries (NYSE: TEVA) shares are trading higher Wednesday after the company reported better-than-expected financial results. 
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital... 
Via Benzinga
Teva Announces $4.25b Opioid Agreement With States, Native American Tribes
Teva has reached an agreement in principle with the working group of States' Attorneys General, counsel for Native American Tribes, and plaintiffs' lawyers representing the States and subdivisions, on... 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
Reuters Monkeypox Emergency Could Last Months, According To Experts 
Via Benzinga
Alphabet, Microsoft And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Pzena Investment Management, Inc (NYSE: PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on! 
Via InvestorPlace
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session
Gainers Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Why Teva Pharmaceuticals Stock Is Soaring After Hours
Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results. 
Via Benzinga
Teva Reports Second Quarter 2022 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
7 Growth Stocks to Buy on the Dip
These are the best growth stocks to buy on the dip. A, CDNS, GXTG, IVSG, IQV, PAYX, and SNPS are poised to deliver impressive returns. 
Via InvestorPlace
Will Bed Bath & Beyond (BBBY) Stock Really Fall to $1?
Bed Bath & Beyond (BBBY) stock is in the news today after an incredibly bearish analyst said the retailer's shares will fall to $1 a piece. 
Via InvestorPlace
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.